Schedule 13G ownership disclosure
Benitec Biopharma LTD/ADR
Security class unavailable · CUSIP: 082053307
Event date: 2019-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,028,980
- Percent of class
- 0.3300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-19-000098
- Form type
- SC 13G
- Filer
- Benitec Biopharma LTD/ADR
- CIK
- CIK 1552795
- Filed
- Oct 08, 2019
- Reporting period
- Sep 30, 2019
- Description
- Schedule 13G beneficial ownership